What's new in the pathogenesis and prevention of ovarian hyperstimulation syndrome?

References

• Abramov Y, Barak V, Nisman B, Schenker JG. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility 1997; 67: 261–265
   PubMed Web of Science ®Google Scholar
• A contemporary overview of PCOS. Reproductive Endocrinology Surgery and Technology, EY Adashi, JA Rock, Z Rosenwaks. Lippencot-Raven Publishers, Philadelphia 1985; 1017–1017, In Chapter 55
   Google Scholar
• Agrawal R, Chimusoro K, Payne N, Van der Spuy Z, Jacobs HS. Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor. Current Opinions in Obstetrics and Gynecology 1997; 9: 141–144
   Google Scholar
• Agrawal R, Conway GS, Tan SL, Sladkevicius P, Engmann L, Payne N, Bekir J, Campbell S, Jacobs HS. Changes in serum vascular endothelial growth factor (VEGF) and Doppler blood flow velocities in in vitro fertilisation cycles: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertility and Sterility 1998a; 70: 651–658
   PubMed Web of Science ®Google Scholar
• Agrawal R, Sladkevicius P, Engmann L, Conway G, Payne N, Tan SL, Campbell S, Jacobs HS. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Human Reproduction 1998b; 13: 651–655
   PubMed Web of Science ®Google Scholar
• Agrawal R, Conway GS, Sladkevicius P, Payne NN, Bekir J, Campbell S, Tan SL, Jacobs HS. Serum vascular endothelial growth factor (VEGF) in the normal menstrual cycle: association with changes in ovarian and uterine Doppler blood flow. Clinical Endocrinology 1999a; 50: 101–106
   PubMedGoogle Scholar
• Agrawal, R, et al, Tan, SL, Wild, S. Serum vascular endothelial growth factor (VEGF) in in vitro fertilisation cycles predicts the risk of ovarian hyperstimulation syndrome. Fertility and Sterility 1999b; 71: 287–293
   PubMed Web of Science ®Google Scholar
• Artini PG, Fasciani A, Monti M, Luisi S, D'Ambrogiou, Genazzani AR. Changes in vascular endothelial growth factor levels and risk of OHSS in women enrolled for an IVF pregnancy. Fertility and Sterility 1998; 70: 560–564
   PubMed Web of Science ®Google Scholar
• Asch RH, Li PP, Balmaceda JP, Weckstein JN, Stone SC. Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high-risk group. Human Reproduction 1991; 6: 1395–1399
   PubMed Web of Science ®Google Scholar
• Brinsden PR, Wada I, Tan SL, Balen A, Jacobs HS. Diagnosis, prevention and management of ovarian hyperstimulation syndrome. British Journal of Obstetrics and Gynecology 1995; 102: 767–772
   PubMedGoogle Scholar
• Connolly DT. Vascular permeability factor: a unique regulator of blood vessel function. Journal of Cell Biochemistry 1991; 47: 219–223
   PubMed Web of Science ®Google Scholar
• Christenson LK, Stouffer RL. Follicle stimulating hormone and luteinising hormone/chorionic gonadotrophin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and postovulatory follicles. Journal of Clinical Endocrinology and Metabolism 1997; 82: 2135–2142
   PubMed Web of Science ®Google Scholar
• Delvigne, A, et al, Demoulin, A, Smitz, J. The ovarian hyperstimulation syndrome in IVF: a Belgian multicentre study — I. Clinical and biochemical features. Human Reproduction 1993a; 8: 1353–1360
   PubMed Web of Science ®Google Scholar
• Delvigne, A, et al, Dubois, M, Batthem, B. The ovarian hyperstimulation syndrome in IVF: a Belgian multicentre study — II. Multiple discriminant analysis for risk prediction. Human Reproduction 1993b; 8: 1361–1366
   PubMed Web of Science ®Google Scholar
• Doldi N, Bassan A, Messa A, Ferrari A. Expression of vascular endothelial growth factor in human luteinised granulosa cells and its correlationship with response to controlled ovarian stimulation. Gynecological Endocrinology 1997; 11: 263–267
   PubMed Web of Science ®Google Scholar
• Elchalal U, Schenker J. The pathogenesis of ovarian hyperstimulation syndrome. Human Reproduction 1997; 12: 1129–1137
   PubMed Web of Science ®Google Scholar
• Franck-Lissbrant I, Haggstrom S, Damsen JE, Bergh A. Testosterone stimulates angiogenesis and vascular growth in the ventral prostate in castrated adult rats. Endocrinology 1998; 139: 451–456
   PubMed Web of Science ®Google Scholar
• Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular endothelial growth factor vascular permeability factor by human granulosa and theca lutein cells. Role in corpus luteum development. American Journal of Pathology 1995; 146: 157–165
   PubMed Web of Science ®Google Scholar
• Krasnow JS, Berga SL, Guzick DS, Zeleznik AJ, Yeo K-T. Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertility and Sterility 1996; 65: 552–555
   PubMed Web of Science ®Google Scholar
• Lee A, Christenson LK, Stouffer RL, Bury KA, Patton PE. Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilisation. Fertility and Sterility 1997; 68: 305–311
   Google Scholar
• Ludwig M, Bauer O, Lopens A, Jelkmann W, Diedrich K. Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation. Human Reproduction 1998; 13: 30–32
   PubMedGoogle Scholar
• MacDougall MJ, Tan SL, Jacobs HS. In vitro fertilisation and the ovarian hyperstimulation syndrome. Human Reproduction 1992; 8: 233–237
   Google Scholar
• McClure N, Healy DL, Paw R, Sullivan J, Beaton L, Hanning RV, Jr, Connolly DT, Robertson DM. Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 1994; 344: 235–243
   PubMed Web of Science ®Google Scholar
• Mathur RS, Joels LA, Jenkins JM. Ovarian hyperstimulation syndrome may be more likely if multiple pregnancy occurs following assisted conception. Acta Geneticae Medicae et Gemellologiae 1995; 44: 233–235
   PubMedGoogle Scholar
• Meirow D, Schenker J, Rosler A. Ovarian hyperstimulation syndrome with low oestradiol in non-classical 17 alpha hydroxylase, 17–20 lyase deficiency: what is the role of oestrogens?. Human Reproduction 1996; 11: 2119–2121
   PubMed Web of Science ®Google Scholar
• Moncayo HE, Penz Koza A, Marth C, Gas HG, Herold M, Moncayo R. Vascular endothelial growth factor in serum and follicular fluid of patients undergoing hormonal stimulation for IVF. Human Reproduction 1998; 13: 3310–3314
   PubMedGoogle Scholar
• Navot, D, et al, Margalioth, EJ, Laufer, N. Direct correlation between plasma renin activity and severe ovarian hyperstimulation syndrome. Fertility and Sterility 1987; 48: 57–61
   PubMed Web of Science ®Google Scholar
• Navot D, Relou A, Birkenfield A, Rabinowitz B, Brzezinski A, Margiolith EJ. Risk factor and prognostic variables in ovarian hyperstimulation syndrome. American Journal of Obstetrics and Gynecology 1988; 159: 210–212
   PubMed Web of Science ®Google Scholar
• Neulen J, Zhaoping Y, Raczek S, Weinder K, Keck C, Weich HA, Marme D, Breckwoldt M. Human chorionic gonadotrophin dependent expression of vascular endothelial growth factor in human granulosa cells and importance in ovarian hyperstimulation syndrome. Journal of Clinical Endocrinology and Metabolism 1995; 80: 1967–1971
   PubMed Web of Science ®Google Scholar
• Ong ACM, Eisen V, Rennie DP, Homburg R, Lachelin GCL, Jacobs HS, Slater JDH. Pathogenesis of ovarian hyperstimulation syndrome: a possible role for ovarian renin. Clinical Endocrinology 1991; 34: 43–49
   PubMed Web of Science ®Google Scholar
• Revel, A, et al, Barak, V, Lavy, Y. Characterisation of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertility and Sterility 1996; 66: 66–71
   PubMedGoogle Scholar
• Rizk B. Ovarian hyperstimulation syndrome. Bourne Hall Textbook of In Vitro Fertilisation and Assisted Conception, PR Brinsden, PA Ransburg. Partheon Publishing, London 1991, In Chapter 23
   Google Scholar
• Rizk B, Aboulghar M. Modern management of ovarian hyperstimulation syndrome. Human Reproduction 1991; 6: 1082–1087
   PubMed Web of Science ®Google Scholar
• Rizk B, Smitz J. Ovarian hyperstimulation syndrome after super-ovulation using GnRH agonists for IVF and related procedures. Human Reproduction 1992; 3: 320–327
   Google Scholar
• Schenker JG. Prevention and treatment of ovarian hyperstimulation syndrome. Human Reproduction 1993; 8: 653–659
   PubMedGoogle Scholar
• Shoham Z, Balen A, Patel AP, Jacobs HS. Results of ovulation induction using human menopausal gonadotrophin or purified follicle-stimulating hormone in hypogonadotrophic hypogonadism patients. Fertility and Sterility 1991; 56: 1048–1053
   PubMed Web of Science ®Google Scholar
• Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Journal of Clinical Investigations 1993; 91: 2235–2243
   PubMed Web of Science ®Google Scholar
• Sladkevicius P, Valentin L, Marsal K. Blood flow velocity in the uterine and ovarian arteries during the normal menstrual cycle. Ultrasound in Obstetrics and Gynecology 1993; 3: 199–208
   PubMed Web of Science ®Google Scholar
• Zaidi J, Campbell S, Pitroff R, Kyei-Mensah A, Shaker A, Jacobs HS, Tan SL. Ovarian stromal blood flow in women with polycystic ovaries — a possible new marker for diagnosis?. Human Reproduction 1995; 10: 1992–1996
   PubMed Web of Science ®Google Scholar